ISM1 and metabolic dysfunction-associated steatotic liver disease: In addition, it was suggested that ISM1 facilitated hepatic DNL inhibition, which prevented lipid accumulation in an NAFLD mouse model, and thus the authors argued that ISM1 signalling indirectly modulates the hepatic lipid accumulation by inhibiting the fatty acid releases from the adipose tissue [81].